PMC:7029759 / 21020-21197
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"471","span":{"begin":167,"end":171},"obj":"Gene"}],"attributes":[{"id":"A471","pred":"tao:has_database_id","subj":"471","obj":"Gene:59272"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" antibody, which is an advantage over neutralizing approaches against the S protein. There are a couple of design considerations when thinking about how to employ the ACE2 antib"}
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T347","span":{"begin":1,"end":9},"obj":"GO:0042571"},{"id":"T346","span":{"begin":74,"end":83},"obj":"PG_1"},{"id":"T345","span":{"begin":167,"end":171},"obj":"G_3;PG_10;PR:000003622"}],"text":" antibody, which is an advantage over neutralizing approaches against the S protein. There are a couple of design considerations when thinking about how to employ the ACE2 antib"}
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T120","span":{"begin":1,"end":9},"obj":"Body_part"},{"id":"T121","span":{"begin":76,"end":83},"obj":"Body_part"}],"attributes":[{"id":"A120","pred":"fma_id","subj":"T120","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A121","pred":"fma_id","subj":"T121","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":" antibody, which is an advantage over neutralizing approaches against the S protein. There are a couple of design considerations when thinking about how to employ the ACE2 antib"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T181","span":{"begin":95,"end":96},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":" antibody, which is an advantage over neutralizing approaches against the S protein. There are a couple of design considerations when thinking about how to employ the ACE2 antib"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T79","span":{"begin":76,"end":83},"obj":"Chemical"}],"attributes":[{"id":"A79","pred":"chebi_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":" antibody, which is an advantage over neutralizing approaches against the S protein. There are a couple of design considerations when thinking about how to employ the ACE2 antib"}